Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-13-365352
Filing Date
2013-09-12
Accepted
2013-09-12 16:50:01
Documents
5
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d590297d10ka.htm 10-K/A 432772
2 EX-23.1 d590297dex231.htm EX-23.1 1690
3 EX-31.1 d590297dex311.htm EX-31.1 7768
4 EX-32.1 d590297dex321.htm EX-32.1 3830
5 GRAPHIC g590297g15h69.jpg GRAPHIC 9405
  Complete submission text file 0001193125-13-365352.txt   460348
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52089 | Film No.: 131094615
SIC: 3841 Surgical & Medical Instruments & Apparatus